Filing Details
- Accession Number:
- 0001123292-15-001249
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-19 16:41:31
- Reporting Period:
- 2015-10-15
- Filing Date:
- 2015-10-19
- Accepted Time:
- 2015-10-19 16:41:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1175505 | Five Prime Therapeutics Inc | FPRX | Pharmaceutical Preparations (2834) | 260038620 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1475714 | T Lewis Williams | C/O Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-10-15 | 22,352 | $27.58 | 344,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-15 | 25,000 | $26.68 | 319,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-15 | 20,096 | $27.36 | 299,497 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-10-15 | 4,904 | $27.98 | 294,593 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2015.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.30 to $27.68, inclusive. The reporting person undertakes to provide to Five Prime Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.09 to $27.01, inclusive.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.93 to $27.92, inclusive.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.93 to $28.00, inclusive.
Billionaire Hedge Funds
